- Browse by Author
Browsing by Author "Benveniste, Etty N."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma(Impact Journals, 2015) Rajbhandari, Rajani; McFarland, Braden C.; Patel, Ashish; Gerigk, Magda; Gray, Kenneth; Fehling, Samuel C.; Bredel, Markus; Berbari, Nicolas F.; Kim, Hyunsoo; Marks, Margaret P.; Meares, Gordon P.; Sinha, Tanvi; Chuang, Jeffrey; Benveniste, Etty N.; Nozell, Susan E.; Biology, School of ScienceGlioblastomas (GBMs) are deadly tumors of the central nervous system. Most GBM exhibit homozygous deletions of the CDKN2A and CDKN2B tumor suppressors at 9p21.3, although loss of CDKN2A/B alone is insufficient to drive gliomagenesis. MIR31HG, which encodes microRNA-31 (miR-31), is a novel non-coding tumor suppressor positioned adjacent to CDKN2A/B at 9p21.3. We have determined that miR-31 expression is compromised in >72% of all GBM, and for patients, this predicts significantly shortened survival times independent of CDKN2A/B status. We show that miR-31 inhibits NF-κB signaling by targeting TRADD, its upstream activator. Moreover, upon reintroduction, miR-31 significantly reduces tumor burden and lengthens survival times in animal models. As such, our work identifies loss of miR-31 as a novel non-coding tumor-driving event in GBM.Item MicroRNA-31 is required for astrocyte specification(Wiley, 2018-05) Meares, Gordon P.; Rajbhandari, Rajani; Gerigk, Magda; Tien, Chih-Liang; Chang, Chenbei; Fehling, Samuel C.; Rowse, Amber; Mulhern, Kayln C.; Nair, Sindhu; Gray, G. Kenneth; Berbari, Nicolas F.; Bredel, Markus; Benveniste, Etty N.; Nozell, Susan E.; Biology, School of SciencePreviously, we determined microRNA-31 (miR-31) is a noncoding tumor suppressive gene frequently deleted in glioblastoma (GBM); miR-31 suppresses tumor growth, in part, by limiting the activity of NF-κB. Herein, we expand our previous studies by characterizing the role of miR-31 during neural precursor cell (NPC) to astrocyte differentiation. We demonstrate that miR-31 expression and activity is suppressed in NPCs by stem cell factors such as Lin28, c-Myc, SOX2 and Oct4. However, during astrocytogenesis, miR-31 is induced by STAT3 and SMAD1/5/8, which mediate astrocyte differentiation. We determined miR-31 is required for terminal astrocyte differentiation, and that the loss of miR-31 impairs this process and/or prevents astrocyte maturation. We demonstrate that miR-31 promotes astrocyte development, in part, by reducing the levels of Lin28, a stem cell factor implicated in NPC renewal. These data suggest that miR-31 deletions may disrupt astrocyte development and/or homeostasis.